Tri Locum Partners LP Praxis Precision Medicines, Inc. Transaction History

Tri Locum Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.87 - $1.71 $25,089 - $49,312	-28,838 Reduced 0.59%	4,855,783 $8.3 Million
Q2 2023 Aug 14, 2023	BUY	$0.83 - $1.18 $1.99 Million - $2.83 Million	2,396,267 Added 96.3%	4,884,621 $5.62 Million
Q1 2023 May 15, 2023	BUY	$0.8 - $4.98 $1.97 Million - $12.3 Million	2,464,207 Added 10205.02%	2,488,354 $2.02 Million
Q4 2022 Feb 14, 2023	BUY	$1.88 - $2.49 $45,396 - $60,126	24,147 New	24,147 $57,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $1.84B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.